Ventas, Inc. (BMV:VTR)
Mexico · Delayed Price · Currency is MXN | Market Cap | 808.49B +40.1% |
| Revenue (ttm) | 112.16B +21.7% |
| Net Income | 4.59B +37.4% |
| EPS | 9.59 +27.7% |
| Shares Out | n/a |
| PE Ratio | 176.11 |
| Forward PE | 123.71 |
| Dividend | 35.96 (2.16%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 3,215 |
| Open | 1,668.90 |
| Previous Close | 1,685.90 |
| Day's Range | 1,668.90 - 1,668.90 |
| 52-Week Range | 1,254.34 - 1,685.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 29, 2026 |
About Ventas
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its ... [Read more]
Financial Performance
In 2025, Ventas's revenue was $5.82 billion, an increase of 18.99% compared to the previous year's $4.89 billion. Earnings were $251.38 million, an increase of 209.76%.
Financial numbers in USD Financial StatementsNews
Ventas price target raised to $72 from $67 at Citi
Citi raised the firm’s price target on Ventas (VTR) to $72 from $67 and keeps a Buy rating on the shares.
Ventas price target raised to $113 from $110 at BofA
BofA raised the firm’s price target on Ventas (VTR) to $113 from $110 and keeps a Buy rating on the shares. Despite earnings beats and FY26 estimate raises from three…
Ventas price target raised to $102 from $97 at Cantor Fitzgerald
Cantor Fitzgerald analyst Richard Anderson raised the firm’s price target on Ventas (VTR) to $102 from $97 and keeps an Overweight rating on the shares. Healthcare REIT results highlight strong…
Ventas Earnings Call Transcript: Q2 2026
Q2 2026 saw robust growth, with 10% same-property NOI and 18% SHOP NOI increases year-over-year. Full-year normalized FFO guidance was raised to $3.85–$3.90 per share, and SHOP is set to comprise 60% of the enterprise by year-end, reflecting strong investment momentum and demographic tailwinds.
Ventas Slides: Q2 2026
Ventas has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Ventas Earnings release: Q2 2026
Ventas released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Ventas Quarterly report: Q2 2026
Ventas has published its Q2 2026 quarterly earnings report on July 30, 2026.
Ventas reports Q2 FFO 97c, consensus 95c
Reports Q2 revenue $1.73B, consensus $1.68B. “Ventas’s (VTR) momentum continued in the second quarter. We delivered strong enterprise results, executing on our strategy to capture the unprecedented op...
Ventas raises FY26 normalized FFO view to $3.85-$3.90 from $3.82-$3.89
Consensus is $3.88.
Ventas Reports 2026 Second Quarter Results
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the second quarter ended June 30, 2026. CEO Remarks “Ventas's momentum continued in the second...
Ventas price target raised to $104 from $98 at Mizuho
Mizuho raised the firm’s price target on Ventas (VTR) to $104 from $98 and keeps an Outperform rating on the shares. The firm adjusted targets in the healthcare real estate…
Ventas initiated with an Equal Weight at Barclays
Barclays analyst Richard Hightower initiated coverage of Ventas (VTR) with an Equal Weight rating and $99 price target While initiating coverage of six healthcare REITs, the analyst tells investors th...
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conferen...
Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and ...
Ventas price target lowered to $88 from $95 at Scotiabank
Scotiabank analyst Nicholas Yulico lowered the firm’s price target on Ventas (VTR) to $88 from $95 and keeps a Sector Perform rating on the shares. The firm sees real estate…
Ventas resumed with an Outperform at Raymond James
Raymond James resumed coverage of Ventas (VTR) with an Outperform rating and $94 price target The senior housing operator portfolio platform continues to deliver solid property-level performance throu...
Ventas price target raised to $100 from $95 at Deutsche Bank
Deutsche Bank analyst Omotayo Okusanya raised the firm’s price target on Ventas (VTR) to $100 from $95 and keeps a Buy rating on the shares after spending time with management.
Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporat...
Ventas affirms FY26 FFO view of $3.82-$3.89, consensus $3.87
Comments taken from investor presentation slides.
Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has issued an investor presentation, which is available on the Company's website at ir.ventasreit...
Ventas Slides: Investor presentation
Ventas has posted slides in relation to its latest quarterly earnings report, which was published on June 1, 2026.
Ventas price target raised to $110 from $102 at BofA
BofA analyst Jeffrey Spector raised the firm’s price target on Ventas (VTR) to $110 from $102 and keeps a Buy rating on the shares after updating models for Q1 earnings…
Ventas price target raised to $95 from $93 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm’s price target on Ventas (VTR) to $95 from $93 and keeps a Sector Perform rating on the shares. The firm is updating its…
Ventas price target raised to $110 from $100 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Ventas (VTR) to $110 from $100 and keeps a Buy rating on the shares. The firm updated its model following the Q1…
Ventas Declares Quarterly Dividend of $0.52 Per Common Share
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.52 per common share. The dividend will be payable in cash on July...